At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
In Brief
A Phase 1 clinical trial evaluating Apremilast Immediate Release, Apremilast Modified Release 1, and 11 other interventions for Healthy Volunteers. Completed, enrolled 80 participants across 1 site.
Detailed Summary
This study will assess up to 12 different oral formulations of apremilast to determine how much apremilast is absorbed by the body compared to a reference formulation.
Study Details
Timeline
Interventions
30 mg immediate release tablets
75 mg oral tablet of prototype modified release (MR) 1
75 mg oral tablet of prototype MR 2
75 mg oral capsule of prototype MR 3
75 mg oral capsule of prototype MR 4
75 mg oral capsule of prototype MR 5
75 mg oral capsule of prototype MR 6
80 mg oral capsule of prototype MR 8
80 mg oral capsule of prototype MR 9
80 mg oral capsule of prototype MR 11
80 mg oral capsule of prototype MR 12
80 mg oral capsule of prototype MR 13
80 mg oral capsule of prototype MR 14